Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

New findings about messenger molecule raise hopes for new drugs

19.01.2006


Uppsala University scientists have developed a new method for measuring the concentration of the messenger substance for cells, cyclic adenosine monophosphate (cAMP), in individual living cells. Thanks to this method, the researchers have been able to see how the same messenger molecule can regulate disparate cell functions. The findings will probably be of great value in the development of new drugs for diabetes, among other diseases. The study is being published in the scientific journal Nature on January 19.



Cyclic adenosine monophosphate (cAMP) is a messenger molecule that transmits signals from the cell surface to govern a number of different functions inside the cell. cAMP is vital for the regulation of metabolism, ion channel activity, secretion, and genetic expression, for instance. In insulin-producing cells cAMP serves as a powerful booster of insulin release.

Four Uppsala researchers have developed a new method that makes it possible to measure the concentration of cAMP in individual living cells. With the new method the scientists have studied insulin-producing cells and found that stimulation with hormones leads to regular variations in the concentration of cAMP.


The scientists have also seen that the frequency of the variations in concentration gives rise to different signals. Short-lived increases in concentration were sufficient to activate calcium ion channels, while a stable increase in concentration was necessary for a cAMP-activated protein to enter the cell nucleus and regulate the expression of genes.

- The pattern of concentration changes thus determines what information the messenger molecule is to convey. In this way, the same messenger substance can regulate disparate cell functions. It has never been demonstrated before that this is how cAMP works, says Anders Tengholm, who leads the study.

The Uppsala study enhances our understanding of the signals that regulate the release of insulin. This is a key finding for diabetes research, since this release is disturbed in patients with type-II diabetes.

The new method will be of great value in the mapping of many cAMP-regulated processes in various types of cells.

- The new ability to measure cAMP will probably facilitate the development of new drugs not only for diabetes but also for disorders of the heart, nervous system, and certain forms of cancer, says Anders Tengholm.

The findings are being published in the journal Nature on January 19. Co-authors are Oleg Dyachok, Yegor Isakov, and Jenny Sågetorp.

Anneli Waara | alfa
Further information:
http://www.uu.se
http://www.nature.com

More articles from Life Sciences:

nachricht Ion treatments for cardiac arrhythmia — Non-invasive alternative to catheter-based surgery
20.01.2017 | GSI Helmholtzzentrum für Schwerionenforschung GmbH

nachricht Seeking structure with metagenome sequences
20.01.2017 | DOE/Joint Genome Institute

All articles from Life Sciences >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Traffic jam in empty space

New success for Konstanz physicists in studying the quantum vacuum

An important step towards a completely new experimental access to quantum physics has been made at University of Konstanz. The team of scientists headed by...

Im Focus: How gut bacteria can make us ill

HZI researchers decipher infection mechanisms of Yersinia and immune responses of the host

Yersiniae cause severe intestinal infections. Studies using Yersinia pseudotuberculosis as a model organism aim to elucidate the infection mechanisms of these...

Im Focus: Interfacial Superconductivity: Magnetic and superconducting order revealed simultaneously

Researchers from the University of Hamburg in Germany, in collaboration with colleagues from the University of Aarhus in Denmark, have synthesized a new superconducting material by growing a few layers of an antiferromagnetic transition-metal chalcogenide on a bismuth-based topological insulator, both being non-superconducting materials.

While superconductivity and magnetism are generally believed to be mutually exclusive, surprisingly, in this new material, superconducting correlations...

Im Focus: Studying fundamental particles in materials

Laser-driving of semimetals allows creating novel quasiparticle states within condensed matter systems and switching between different states on ultrafast time scales

Studying properties of fundamental particles in condensed matter systems is a promising approach to quantum field theory. Quasiparticles offer the opportunity...

Im Focus: Designing Architecture with Solar Building Envelopes

Among the general public, solar thermal energy is currently associated with dark blue, rectangular collectors on building roofs. Technologies are needed for aesthetically high quality architecture which offer the architect more room for manoeuvre when it comes to low- and plus-energy buildings. With the “ArKol” project, researchers at Fraunhofer ISE together with partners are currently developing two façade collectors for solar thermal energy generation, which permit a high degree of design flexibility: a strip collector for opaque façade sections and a solar thermal blind for transparent sections. The current state of the two developments will be presented at the BAU 2017 trade fair.

As part of the “ArKol – development of architecturally highly integrated façade collectors with heat pipes” project, Fraunhofer ISE together with its partners...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

Sustainable Water use in Agriculture in Eastern Europe and Central Asia

19.01.2017 | Event News

12V, 48V, high-voltage – trends in E/E automotive architecture

10.01.2017 | Event News

2nd Conference on Non-Textual Information on 10 and 11 May 2017 in Hannover

09.01.2017 | Event News

 
Latest News

Helmholtz International Fellow Award for Sarah Amalia Teichmann

20.01.2017 | Awards Funding

An innovative high-performance material: biofibers made from green lacewing silk

20.01.2017 | Materials Sciences

Ion treatments for cardiac arrhythmia — Non-invasive alternative to catheter-based surgery

20.01.2017 | Life Sciences

VideoLinks
B2B-VideoLinks
More VideoLinks >>>